Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)

India flag India · Delayed Price · Currency is INR
506.00
+2.65 (0.53%)
At close: Dec 5, 2025
Market Cap 159.98B
Revenue (ttm) 18.77B
Net Income (ttm) 1.15B
Shares Out 316.17M
EPS (ttm) 3.63
PE Ratio 139.57
Forward PE 105.56
Dividend n/a
Ex-Dividend Date n/a
Volume 83,301
Average Volume 313,391
Open 500.05
Previous Close 503.35
Day's Range 495.00 - 508.50
52-Week Range 327.00 - 568.00
Beta n/a
RSI 47.15
Earnings Date Jan 29, 2026

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr... [Read more]

Sector Healthcare
Founded 2010
Employees 4,214
Stock Exchange National Stock Exchange of India
Ticker Symbol AGARWALEYE
Full Company Profile

Financial Performance

In 2024, Dr. Agarwal's Health Care's revenue was 17.11 billion, an increase of 28.44% compared to the previous year's 13.32 billion. Earnings were 834.60 million, an increase of 0.48%.

Financial Statements

News

There is no news available yet.